|
ZFP37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.975200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.337200E-01 |
| Normal-vs-Stage2 |
3.616600E-01 |
| Normal-vs-Stage3 |
2.495200E-01 |
| Normal-vs-Stage4 |
4.340200E-01 |
| Stage1-vs-Stage2 |
3.292600E-01 |
| Stage1-vs-Stage3 |
1.618570E-01 |
| Stage1-vs-Stage4 |
3.558600E-01 |
| Stage2-vs-Stage3 |
9.732400E-01 |
| Stage2-vs-Stage4 |
8.246400E-01 |
| Stage3-vs-Stage4 |
7.637800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.578000E-01 |
| Normal-vs-AfricanAmerican |
5.401600E-01 |
| Normal-vs-Asian |
3.041400E-01 |
| Caucasian-vs-AfricanAmerican |
2.207200E-01 |
| Caucasian-vs-Asian |
5.161600E-02 |
| AfricanAmerican-vs-Asian |
8.490600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.101400E-01 |
| Normal-vs-Female |
7.526400E-01 |
| Male-vs-Female |
3.087800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.552000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.316400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.174200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.641600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.813800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.521800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.554400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.906240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.251400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.905000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.065700E-02 |
| Classical-VS-Follicular |
1.241780E-02 |
| Classical-VS-Other |
7.162000E-01 |
| Classical-VS-Normal |
7.626400E-01 |
| Tall-VS-Follicular |
5.366200E-01 |
| Tall-VS-Other |
3.206800E-01 |
| Tall-VS-Normal |
6.529700E-02 |
| Follicular-VS-Other |
2.711400E-01 |
| Follicular-VS-Normal |
1.433950E-01 |
| Other-VS-Normal |
6.539400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.897200E-01 |
| Normal-vs-N1 |
2.769400E-01 |
| N0-vs-N1 |
4.970400E-01 |
|
|
